scholarly journals Dietary Supplements: The New Herbalism

2003 ◽  
Vol 13 (2) ◽  
pp. 239-242
Author(s):  
Lyle E. Craker ◽  
Zoë Gardner

The passage of the Dietary Supplement Health and Education Act in 1994 made the use of supplements more acceptable in the U.S., increasing demand for botanicals to use in health care and maintenance. These botanicals, primarily medicinal and aromatic plants, currently represent about 25% of the dietary supplement market in the U.S. Although much of the market for botanicals traditionally has been met through collection of plants in the wild, enhanced cultivation of several species will be essential to bring standardized, quality plant materials into the marketplace.

LAW REVIEW ◽  
2018 ◽  
Vol 37 (01) ◽  
Author(s):  
Priti Atrey

Uttarakhand popularly known as Dev Bhumi is widely believed to be the source of the centuries old traditional system of medicine called Ayurveda. The State is blessed with thousand of species; however, about 320 species have been identified having commonly growing. The forest department has reported about 175 species being commercially extracted and traded. The State Government in 2003 declared Uttarakhand as an Herbal State. After declaration of Uttarakhand as an Herbal State, the government took initiatives for sustainable cultivation of medicinal and aromatic plants in a phased manner. As it is a newly formed state, Uttarakhand is being subject to many large projects especially hydroelectric projects, as part of development. These will adversely impact the forestland of the state. Many species of medicinal and aromatic plants have disappeared with the loss of oak forests. There is growing evidence that the many medicinal and aromatic plants species are declining in the wild. So the systematic cultivation of high value medicinal and aromatic plants under prevailing agro ecological condition is one of the sincere efforts in the direction of sustainable development. Recently the state Government has introduced several incentives and established The Herbal Research and Development Institute, State Medicinal Plants Board and Center for Aromatic Plants for the popularization of sustainable cultivation of medicinal and aromatic plants. In these circumstances, our major objective is to explore the potential in medicinal and aromatic plants cultivation in Uttarakhand.


2005 ◽  
Vol 31 (2-3) ◽  
pp. 285-304 ◽  
Author(s):  
Scott Bass ◽  
Emily Marden

In the ten years since the passage of the Dietary Supplement Health and Education Act of 1994 (“DSHEA”), dietary supplements have become a widely available and important element of individualized preventative healthcare. Congress created DSHEA in response to great consumer demand, thereby embracing the dietary supplement category and opening the door for the growth of the dietary supplement industry. DSHEA introduced an expansive definition of dietary supplements and laid out available claims and strict safety standards for such products.While the statute has remained unchanged since its passage in 1994, the Food and Drug Administration (“FDA”) appears to be in the process of re-interpreting sections of DSHEA in ways that could fundamentally limit the availability of dietary supplements. Specifically, FDA has been utilizing DSHEA's “new dietary ingredient” (“NDI”) safety provision to narrow the scope of ingredients that can be considered, even before addressing their safety, for use in dietary supplements.


2004 ◽  
Vol 9 (2) ◽  
pp. 110-116
Author(s):  
Roberta M. Tankanow ◽  
Kelly A. Dwyer ◽  
Darcie-Ann Streetman

OBJECTIVES Patients are assuming responsibility for their own health by self-medicating with dietary supplements, often without physician knowledge or oversight. The objectives of this study were to determine: 1) pediatric dietary supplement use by surveying parents of children who were hospitalized in a university institution; 2) if any health care professional inquired about supplement use at the time the child was hospitalized; 3) whether the use of a supplement was documented in the patient's medical record; and 4) parents' attitudes about dietary supplements. STUDY DESIGN Parents of 100 hospitalized pediatric patients (<18 years of age) were randomly selected to complete a survey about their child's use of dietary supplements prior to and during hospitalization. They were also asked if they intended to use these products after hospitalization. The purpose of the study was explained, informed consent was obtained, and parents were given ample time to complete the survey. RESULTS Fifty percent of parents reported giving their child a dietary supplement prior to hospitalization; 17% reported use of an herbal supplement. Only 24% of parents reported being asked about supplement use by a health care professional upon admission or during the hospital stay. The response to only five of these queries was documented in the child's medical record. CONCLUSIONS Increasing dietary supplement use mandates that all health care professionals elicit this information as part of the routine History and Physical Examination at the time a child is hospitalized. This information should also be documented in the patient's medical record. Likewise, parents should be encouraged to discuss the use of these products with their physician and pharmacist.


2011 ◽  
Vol 94 (3) ◽  
pp. 803-814 ◽  
Author(s):  
Melissa M Phillips ◽  
Catherine A Rimmer ◽  
Laura J Wood ◽  
Katrice A Lippa ◽  
Katherine E Sharpless ◽  
...  

Abstract The National Institute of Standards and Technology (NIST) has established a Dietary Supplement Laboratory Quality Assurance Program (DSQAP) in collaboration with the National Institutes of Health Office of Dietary Supplements. Program participants measure concentrations of active and/or marker compounds as well as nutritional and toxic elements in food and dietary supplements distributed by NIST. Data are compiled at NIST, where they are analyzed for accuracy relative to reference values and concordance among the participants. Performance reports and certificates of completion are provided to participants, which can be used to demonstrate compliance with current Good Manufacturing Practices as promulgated by the U.S. Food and Drug Administration. The DSQAP has conducted five exercises to date, with total participation including more than 75 different laboratories and many more individual analysts.


2021 ◽  
Vol 67 (3) ◽  
pp. 1-18
Author(s):  
Joanna Sucholas ◽  
Mariya Ukhanova ◽  
Anja Greinwald ◽  
Rainer Luick

Summary Introduction: Poland is one of the main exporters of medicinal and aromatic plants (MAPs) in Europe. A substantial part of this plant material is collected in the wild. So far, the system of wild collection (WC) of medicinal plants in Poland, its social and ecological aspects have not been studied comprehensively. Objective: The aim of the study was to analyse the organisation of WC system in Poland, including legislation, situation of protected species, and socio-ecological dimensions of the MAPs’ supply chains. Methods: Data from environmental agencies (RDOŚ) about protected MAPs was analysed. Stakeholders engaged in WC were interviewed. National legislation on WC was reviewed. Results: Although Poland is the second largest exporter of MAPs in Europe, legislation on wild collection in the country is sparse and incoherent. Monitoring does not apply to WC entirely. The structure of WC has a large degree of informality, lacks transparency, and does not take many sustainability criteria into account. Conclusions: The system needs major adjustments: a) to insure sustainability of WC, b) to accommodate market demands, including plant material quality.


2003 ◽  
Vol 22 (5) ◽  
pp. 391-392 ◽  
Author(s):  
Stephen Barrett

Federal agencies have never had enough resources to cope with the enormous amount of deception in the supplement and health-food marketplace. Passage of the 1994 Dietary Supplement Health and Education Act (DSHEA) has worsened the situation by encouraging dubious claims and weakening the Food and Drug Administration (FDA)'s ability to ban dangerous products.


2017 ◽  
Vol 27 (4) ◽  
pp. 325-334 ◽  
Author(s):  
Bryan E. Denham

In the United States, the Dietary Supplement Health and Education Act of 1994 (DSHEA) classified dietary supplements as a subcategory of food, exempting manufacturers from providing premarket evidence of product safety and efficacy. Under DSHEA, agencies such as the U.S. Food and Drug Administration (FDA) cannot inspect supplements until after the products have entered the marketplace. Recognizing that both limited resources and DSHEA prevent the FDA from conducting broad-based inspections on a regular basis, disreputable manufacturers have spiked products with drugs such as anabolic steroids and amphetamines. With contaminated supplements now causing athletes to fail drug tests and, in some instances, threatening public health, it becomes important to examine sources of supplement information. This article reviews 53 studies that have addressed athlete information sources about dietary supplements. It finds that athletes, in general, rely heavily on coaches and trainers as well as friends and family for information. Relative to U.S. athletes, those competing internationally appear more likely to seek information from a physician or nutritionist. The article offers recommendations for individuals and organizations based on the most frequent information sources identified by athletes.


1999 ◽  
Vol 2 (1) ◽  
pp. 35-38 ◽  
Author(s):  
Malden C Nesheim

AbstractThe market for dietary supplements in the USA was estimated as about 11.8 billion dollars in 1997 with a growth rate of 10–14 % projected in the next 3 years. Data from the Food and Drug Administration collected in 1995 indicate that over 55 % of adults surveyed used some type of dietary supplement. The marketing of dietary supplements in the USA has been essentially deregulated by the passage of the Dietary Supplement Health and Education Act of 1994 (DSHEA). This legislation defined dietary supplements, made manufacturers responsible for the safety of supplements and allowed certain statements of nutrition support to be made on supplement labels. The US Congress in passing the DSHEA indicated that supplements should be available on the market so that consumers could make decisions about their use for themselves and their families. Unfortunately, information about the research base for supplement claims is not readily accessible to health professionals and consumers. There is a need for authoritative reviews of the data underlying supplement claims to assist public health professionals in their role of providing advice to the public about dietary supplements.


Sign in / Sign up

Export Citation Format

Share Document